L Dahl - JoVE Visualize

Showing results (191-200 of 305) with videos related to

Pageof 31

Sort By:

Journal of Bacteriology|April 15, 2008

Inactivation of lsr2 results in a hypermotile phenotype in Mycobacterium smegmatisKriti Arora, Danelle C Whiteford, Dalia Lau-Bonilla, et al.

Gastroenterology|February 1, 1987

Effect of chemical ablation of myenteric neurons on neurotransmitter levels in the rat jejunumJ L Dahl, D D Bloom, M L Epstein, et al.

Psychiatric Genetics|June 13, 1998

Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophreniaE G Jönsson, M L Dahl, H K Roh, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 10, 1998

1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humansB Eiermann, P O Edlund, A Tjernberg, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquineI Johansson, E Lundqvist, L Bertilsson, et al.

European Journal of Clinical Pharmacology|January 1, 1992

Nonlinearity of amoxicillin absorption kinetics in humanG Paintaud, G Alván, M L Dahl, et al.

Journal of Pain and Symptom Management|March 28, 2006

Institutionalizing effective pain management practices: practice change programs to improve the quality of pain management in small health care organizationsKaren M Stevenson, June L Dahl, Patricia H Berry, et al.

Psychopharmacology|January 20, 2000

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidoneM G Scordo, E Spina, G Facciolà, et al.

Biochemical and Biophysical Research Communications|January 28, 1999

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish populationU Yasar, E Eliasson, M L Dahl, et al.

Bulletin of the World Health Organization|January 1, 1990

Metrifonate in healthy volunteers: interrelationship between pharmacokinetic properties, cholinesterase inhibition and side-effectsY Aden-Abdi, T Villén, O Ericsson, et al.

Pageof 31

Showing results (191-200 of 305) with videos related to

Sort By:

Pageof 31

Journal of Bacteriology|April 15, 2008

Inactivation of lsr2 results in a hypermotile phenotype in Mycobacterium smegmatisKriti Arora, Danelle C Whiteford, Dalia Lau-Bonilla, et al.

Gastroenterology|February 1, 1987

Effect of chemical ablation of myenteric neurons on neurotransmitter levels in the rat jejunumJ L Dahl, D D Bloom, M L Epstein, et al.

Psychiatric Genetics|June 13, 1998

Lack of association between debrisoquine 4-hydroxylase (CYP2D6) gene polymorphisms and schizophreniaE G Jönsson, M L Dahl, H K Roh, et al.

Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 10, 1998

1- and 3-hydroxylations, in addition to 4-hydroxylation, of debrisoquine are catalyzed by cytochrome P450 2D6 in humansB Eiermann, P O Edlund, A Tjernberg, et al.

Proceedings of the National Academy of Sciences of the United States of America|December 15, 1993

Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquineI Johansson, E Lundqvist, L Bertilsson, et al.

European Journal of Clinical Pharmacology|January 1, 1992

Nonlinearity of amoxicillin absorption kinetics in humanG Paintaud, G Alván, M L Dahl, et al.

Journal of Pain and Symptom Management|March 28, 2006

Institutionalizing effective pain management practices: practice change programs to improve the quality of pain management in small health care organizationsKaren M Stevenson, June L Dahl, Patricia H Berry, et al.

Psychopharmacology|January 20, 2000

Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidoneM G Scordo, E Spina, G Facciolà, et al.

Biochemical and Biophysical Research Communications|January 28, 1999

Validation of methods for CYP2C9 genotyping: frequencies of mutant alleles in a Swedish populationU Yasar, E Eliasson, M L Dahl, et al.

Bulletin of the World Health Organization|January 1, 1990

Metrifonate in healthy volunteers: interrelationship between pharmacokinetic properties, cholinesterase inhibition and side-effectsY Aden-Abdi, T Villén, O Ericsson, et al.

Pageof 31